Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02613299 · ClinicalTrials.gov registry record
Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 5
- Enrollment target
NCT02613299: Clinical Trial study, sponsored by Mayo Clinic.
NCT02613299 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02613299 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether radiation therapy decreases tumor size and tumor spread. The investigators will consent subjects that have been diagnosed with mesothelioma and will undergo radiation therapy followed by surgical resection as their standard of care. The investigators will collect data from past and future medical records as well as data regarding their health status for their lifetime by reviewing life status, treatment status and CT scans.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-06-14 |
| Est. Completion | 2025-05-29 |
Why NCT02613299 stopped before completion
NCT02613299 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02613299 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02613299 about?
NCT02613299 is a clinical study titled "Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma". The purpose of this study is to determine whether radiation therapy decreases tumor size and tumor spread. The investigators will consent subjects that have been diagnosed with mesothelioma and will undergo radiation therapy followed by surgical resection as their standard of care. The investigators...
What is the current status of trial NCT02613299?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2016-06-14. Estimated completion is 2025-05-29.
Who is sponsoring clinical trial NCT02613299?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI